Nautilus Biotechnolgy
NAUT
NAUT
73 hedge funds and large institutions have $186M invested in Nautilus Biotechnolgy in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 76 → 73 (-3)
32% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 25
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
73
Holding in Top 10
3
Calls
$41K
Puts
$5K
Top Buyers
| 1 | +$468K | |
| 2 | +$232K | |
| 3 | +$123K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87K |
| 5 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$65K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$476K | |
| 3 | -$193K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$174K |
| 5 |
Barclays
London,
United Kingdom
|
-$99.7K |